Age: 0-14 years Chronic obstructive 15-64 years: No n/a n/a n/a n/a No CRF pulmonary disease effect recommended. (COPD) 64+ years: No effect () No effect in 1-hour maximum. Australian 2-cities Lag 01. meta-analysis (). Meta-analysis of 2 cities - Brisbane, Sydney. Moderate to high heterogeneity lCD9: 490-492, ICDI0: J47, J67 Pneumonia and 0 years: No effect. n/a n/a n/a n/a No CRF acute bronchitis 1-4 years: 8.5% recommended. (3.0-14.3%) per 5.4 ppb. No effect in 1-4 years, two Australian 2-cities pollutant model with meta-analysis (). PM2.5: No effect. 15-64 years: No effect. 65+ years: No effect () 1-hour maximum Lag 01 Meta-analysis of 2 cities - Brisbane, Sydney Moderate to high
Age: 0-14 years Chronic obstructive pulmonary disease (COPD) 15-64 years: No effect 64+ years: No effect () 1-hour maximum. Lag 01. Meta-analysis of 2 cities - Brisbane, Sydney. Moderate to high heterogeneity lCD9: 490-492, ICDI0: J47, J67 n/a n/a n/a n/a No CRF recommended. No effect in Australian 2-cities meta-analysis (). Pneumonia and acute bronchitis 0 years: No effect. 1-4 years: 8.5% (3.0-14.3%) per 5.4 ppb. 1-4 years, two pollutant model with PM2.5: No effect. 15-64 years: No effect. 65+ years: No effect () 1-hour maximum Lag 01 Meta-analysis of 2 cities - Brisbane, Sydney Moderate to high n/a n/a n/a n/a No CRF recommended. No effect in Australian 2-cities meta-analysis ().